Molecular Mechanisms of Natural Killer Cell Cytokine-Activation
自然杀伤细胞细胞因子激活的分子机制
基本信息
- 批准号:8427391
- 负责人:
- 金额:$ 11.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-26 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:Activated Natural Killer CellAddressAdvisory CommitteesAntigensBindingBinding SitesCancer PatientCell-Mediated CytolysisCellsCellular biologyCodeCytokine ActivationCytokine SignalingDatabasesDiseaseDoctor of PhilosophyFosteringFoundationsGene Expression ProfileGenerationsGenesGeneticGenetic TranslationGenomicsGoalsHealthHematologic NeoplasmsHematologyHematopoietic NeoplasmsImmuneImmune systemImmunityImmunologic MonitoringIn VitroInstructionInterferonsInternal MedicineLaboratoriesLeadLymphocyteMalignant - descriptorMalignant NeoplasmsMediatingMedicalMedicineMentorsMessenger RNAMicroRNAsMolecularMolecular ProfilingMusNK Cell ActivationNatural Killer CellsPathway interactionsPhysiciansPopulationPost-Transcriptional RegulationPrincipal InvestigatorProtein DatabasesProteinsProteomeProteomicsRegulationResearchRestRoleScientistTechniquesTechnologyTrainingTraining ProgramsTranscriptional RegulationTranslationsUniversitiesVirusWashingtonWorkbasecareercareer developmentcytokinecytotoxiccytotoxicityexperiencegranzyme Bin vivokillingsleukemiamRNA Transcript Degradationmouse modelnoveloncologyparacrinepathogenperforinprogramsprotein expressionprotein profilingresearch study
项目摘要
The long term goal of this proposal is to train the applicant to become an independent academic physician-
scientist studying the innate immune system and its impact on blood cancers. The principal investigator (PI)
has completed PhD training focused on the cellular biology of natural killer (NK) cells, and MD training in
internal medicine and hematology-oncology. This application describes a 5 year training program that will
provide a mentored educational experience aimed at developing new scientific expertise in molecular
profiling, massively parallel sequencing, proteomic analysis, manipulation of microRNAs (miRs), and the
generation of mouse models. Dr. Timothy Ley will mentor the Pi's scientific and career development. He is
a recognized leader in the field of lymphocyte cytotoxicity, in vivo genetic mouse models, and genomic
analysis of leukemia. Furthermore, an advisory committee of medical scientist experts will provide additional
scientific and and non-scientific career development guidance.
The proposed research will evaluate the role of miRs in the regulation of NK cell cytokine activation.
Recent work by the PI in Dr. Ley's laboratory identified two critical cytotoxic molecules, granzyme B (GzmB)
and perforin (Prf1), that are post-transcriptionally regulated in NK cells. We hypothesize that miRs regulate
GzmB and Prf1 in resting NK cells, and that cytokine-activation releases their block in translation.
To address this hypothesis, we propose the following specific aims:
1) We will define the miR expression profiles in resting and cytokine-activated NK cells, and evaluate
candidate miRs that may regulate GzmB and Prfl mRNA translation.
2) We will define the mRNA (transcriptome) and protein (proteome) expression profiles of resting and
cytokine-activated NK cells, integrate these databases to define the mode of regulation of
molecules important during NK cell activation, and define the role of miRs for post-transcriptional
regulation.
Techniques utilized in the project include miR sequencing, miR microarrays, in vitro and in vivo
manipulation of miRs, the generation of a NK cell-specific Cre mouse model, the generation of genetic
mouse models deficient in miRs using Cre-Lox, and the global analysis of the NK cell transcriptome and
proteome. Washington University provides an ideal setting to train physician-scientists, and will foster an
invaluable mentored eduational experience for the PI to realize his career goals in academic medicine.
RELEVANCE (See instructions):
This overall career development proposal will train an independent physician-scientist for a lifetime of
research studying the immune system and cancer. As NK cells are key components of immunity to
numerous infectious pathogens, and are involved in the immunosurveillance of malignancy, the research
proposed may have far reaching consequences for health and disease. Specifically, a better understanding
of NK cell activation may lead to novel immune based stategies to treat hematologic malignancies.
本提案的长期目标是培养申请人成为一名独立的学术医生-
研究先天免疫系统及其对血癌影响的科学家。主要研究者(PI)
已经完成了博士培训,重点是自然杀伤(NK)细胞的细胞生物学,和医学博士培训,
内科学和血液肿瘤学。此应用程序描述了一个5年的培训计划,将
提供一个指导的教育经验,旨在发展新的科学专业知识的分子
分析、大规模平行测序、蛋白质组学分析、微RNA(miRs)的操作,以及
小鼠模型的产生。Timothy Ley博士将指导Pi的科学和职业发展。他是
在淋巴细胞毒性、体内遗传小鼠模型和基因组学领域的公认领导者
白血病分析此外,一个由医学专家组成的咨询委员会将提供额外的
科学的和非科学的职业发展指导。
该研究将评估miR在NK细胞细胞因子活化调节中的作用。
PI在Ley博士实验室的最新工作确定了两种关键的细胞毒性分子,颗粒酶B(Gzm B)
和穿孔素(Prf 1),它们在NK细胞中受到转录后调节。我们假设miR调节
GzmB和Prf 1在静息NK细胞中的表达,并且精氨酸激活释放了它们在翻译中的阻滞。
为了解决这一假设,我们提出以下具体目标:
1)我们将定义静息和丝氨酸激活的NK细胞中的miR表达谱,并评估
可以调节GzmB和Prf 1 mRNA翻译的候选miR。
2)我们将定义静息和静息状态下的mRNA(转录组)和蛋白质(蛋白质组)表达谱,
整合这些数据库,以确定调节NK细胞的模式。
在NK细胞活化过程中重要的分子,并定义了转录后miR的作用,
调控
该项目中使用的技术包括miR测序,miR微阵列,体外和体内
miR的操作,NK细胞特异性Cre小鼠模型的产生,遗传修饰的产生,
使用Cre-Lox的miRs缺陷小鼠模型,以及NK细胞转录组和
蛋白质组华盛顿大学提供了一个理想的环境,以培养医生,科学家,并将培养一个
宝贵的指导教育经验,为PI实现他的职业目标,在学术医学。
相关性(参见说明):
这个整体的职业发展建议将培养一个独立的医生,科学家的一生,
研究免疫系统和癌症的研究。由于NK细胞是免疫的关键组成部分,
许多感染性病原体,并参与恶性肿瘤的免疫监视,研究
可能对健康和疾病产生深远的影响。具体来说,更好地理解
NK细胞活化的研究可能会导致新的基于免疫的策略来治疗血液恶性肿瘤。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
MicroRNA regulation of natural killer cells.
- DOI:10.3389/fimmu.2013.00044
- 发表时间:2013
- 期刊:
- 影响因子:7.3
- 作者:Sullivan RP;Leong JW;Fehniger TA
- 通讯作者:Fehniger TA
Natural killer cell regulation by microRNAs in health and disease.
- DOI:10.1155/2012/632329
- 发表时间:2012
- 期刊:
- 影响因子:0
- 作者:Leong JW;Sullivan RP;Fehniger TA
- 通讯作者:Fehniger TA
microRNA management of NK-cell developmental and functional programs.
- DOI:10.1002/eji.201444798
- 发表时间:2014-10
- 期刊:
- 影响因子:5.4
- 作者:Leong, Jeffrey W.;Sullivan, Ryan P.;Fehniger, Todd A.
- 通讯作者:Fehniger, Todd A.
Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer.
- DOI:10.1155/2014/205796
- 发表时间:2014
- 期刊:
- 影响因子:3.2
- 作者:Romee R;Leong JW;Fehniger TA
- 通讯作者:Fehniger TA
MicroRNA-deficient NK cells exhibit decreased survival but enhanced function.
缺乏microRNA的NK细胞表现出降低的存活率,但功能增强。
- DOI:10.4049/jimmunol.1102294
- 发表时间:2012-04-01
- 期刊:
- 影响因子:0
- 作者:Sullivan RP;Leong JW;Schneider SE;Keppel CR;Germino E;French AR;Fehniger TA
- 通讯作者:Fehniger TA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TODD A FEHNIGER其他文献
TODD A FEHNIGER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TODD A FEHNIGER', 18)}}的其他基金
TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPY
将 NK 细胞生物学转化为临床癌症免疫治疗
- 批准号:
9767734 - 财政年份:2017
- 资助金额:
$ 11.65万 - 项目类别:
TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPY
将 NK 细胞生物学转化为临床癌症免疫治疗
- 批准号:
10017898 - 财政年份:2017
- 资助金额:
$ 11.65万 - 项目类别:
Project 5 - Memory-like NK cell augmented hematopoietic cell transplantation for AML.
项目 5 - 记忆样 NK 细胞增强造血细胞移植治疗 AML。
- 批准号:
10439627 - 财政年份:2013
- 资助金额:
$ 11.65万 - 项目类别:
MICRORNA REGULATION OF NK CELL DEVELOPMENT AND FUNCTION
微小RNA对NK细胞发育和功能的调节
- 批准号:
8583090 - 财政年份:2013
- 资助金额:
$ 11.65万 - 项目类别:
MICRORNA REGULATION OF NK CELL DEVELOPMENT AND FUNCTION
微小RNA对NK细胞发育和功能的调节
- 批准号:
8715686 - 财政年份:2013
- 资助金额:
$ 11.65万 - 项目类别:
MICRORNA REGULATION OF NK CELL DEVELOPMENT AND FUNCTION
微小RNA对NK细胞发育和功能的调节
- 批准号:
8890768 - 财政年份:2013
- 资助金额:
$ 11.65万 - 项目类别:
Project 5 - Memory-like NK cell augmented hematopoietic cell transplantation for AML.
项目 5 - 记忆样 NK 细胞增强造血细胞移植治疗 AML。
- 批准号:
10931079 - 财政年份:2013
- 资助金额:
$ 11.65万 - 项目类别:
Project 5 - Memory-like NK cell augmented hematopoietic cell transplantation for AML.
项目 5 - 记忆样 NK 细胞增强造血细胞移植治疗 AML。
- 批准号:
10194404 - 财政年份:2013
- 资助金额:
$ 11.65万 - 项目类别:
MICRORNA REGULATION OF NK CELL DEVELOPMENT AND FUNCTION
微小RNA对NK细胞发育和功能的调节
- 批准号:
9097519 - 财政年份:2013
- 资助金额:
$ 11.65万 - 项目类别:
Molecular Mechanisms of Natural Killer Cell Cytokine-Activation
自然杀伤细胞细胞因子激活的分子机制
- 批准号:
7810611 - 财政年份:2009
- 资助金额:
$ 11.65万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Research Grant